Mass Spectrometry Market | Sciex (US) Enhancing its Product Development Capabilities
ID: 1711922
The overall mass spectrometry market is expected to grow from USD 3.44 billion in 2016 to USD 5.27 billion by 2022, at a CAGR of 7.4%
Mass Spectrometry Market(firmenpresse) - According to a new market research report "Mass Spectrometry Market by Platform (Hybrid mass spectrometry (Triple Quadrupole, QTOF & FTMS), Single mass spectrometry (Quadrupole, TOF & Ion Trap)), Application (Pharmaceuticals, Biotechnology, Environmental testing) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 5.27 Billion by 2022 from an estimated USD 3.68 Billion in 2017, at a CAGR of 7.4%.
The key factors which include the growth of the mass spectrometry market are pharmaceutical and biotechnology industry and technological advancements in mass spectrometry. The growing use of mass spectrometry in emerging markets and the rising potential for the application of high-resolution mass spectrometry in healthcare are the key areas of opportunity in this market.
Don’t miss the opportunities in global Mass Spectrometry Market. Speak to our Analyst for more detailed Information: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=437
Sciex under Danaher Corporation (US) dominated the mass spectrometry market in 2016. The company provides a wide range of mass spectrometry technologies, accessories, and software in the mass spectrometry market. These products find application in a range of industries including pharmaceuticals, environmental agencies, food & beverage, petroleum industry, and research laboratories. To maintain its leading position and increase its customer base in the mass spectrometry market, the company mainly focuses on expanding its market presence by enhancing its product development capabilities and product launches & enhancements. For instance, in 2017, the company launched the Topaz LC-MS/MS System and the software called BioPharmaView 1.5 Software, an addition to its existing portfolio. The company has a strong R&D and manufacturing infrastructure, with its presence in Europe, North and South America, Asia, Africa, the Middle East and the Rest of the World.
By technology, the hybrid mass spectrometry segment accounted for the largest share of the market in 2017
On the basis of technology, the Mass Spectrometry Market is broadly segmented into single mass spectrometry, hybrid mass spectrometry, and other mass spectrometry technologies (magnetic sector, inductively coupled plasma mass spectrometry). In 2017, the hybrid mass spectrometry segment is expected to account for the largest share of this market. The extensive applications of hybrid mass spectrometers coupled with the technological advancements in mass spectrometry are driving the growth of this segment.
Browse and in-depth TOC on "Mass Spectrometry Market"
109 - Tables
36 - Figures
176 – Pages
Request Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=437
By application, the pharmaceutical application industry held the largest market share in 2017
Based on application, the Mass Spectrometry Market is further segmented into pharmaceutical application, biotech application, environmental testing, food and beverage testing, petrochemical applications, and other applications. In 2017, the pharmaceutical applications segment is expected to account for the largest share. Extensive use of mass spectrometry technologies at various stages of drug development processes and increase in R&D investments by pharmaceutical industries are driving the growth of the market.
North America dominated the market in 2017
North America accounted for the largest share of the Mass Spectrometry Market in 2016, followed by Europe. High usage of mass spectrometry in the pharmaceutical sector, growing funding to favor Mass Spectrometry Market in the US, high petrol and natural gas production, growing biopharmaceuticals and biotechnology research & development and fundings for innovation based projects in Canada is expected to drive market during the forecast period.
Factors such as availability of funds for research, growing cosmetics industry in Germany, growing food safety concerns and increased investments for pharmaceuticals in the UK, favorable scenario of biotechnology and pharmaceutical industry in Italy, company's expansion in France and strong food and beverage industry in Spain are driving factors of the European Mass Spectrometry Market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437
Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), and SCIEX (Subsidiary of Danaher) (US) are the key players in the Mass Spectrometry Market. Other players involved in this market are Bruker (US), PerkinElmer (US), JEOL (Japan), Analytik Jena (Germany), Hiden Analytical (UK), Rigaku (Japan), LECO (US), and DANI Instruments (Italy).
Weitere Infos zu dieser Pressemeldung:
Themen in dieser Pressemitteilung:
mass-spectrometry-market
mass-spectrometry-market-growth
mass-spectrometry-market-size
mass-spectrometry-market-analysis
mass-spectrometry-market-outlook
mass-spectrometry-market-latest-trends
mass-spectrometry-market-intelligence
mass-spectrometry
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 05.04.2019 - 11:28 Uhr
Sprache: Deutsch
News-ID 1711922
Anzahl Zeichen: 5070
Kontakt-Informationen:
Ansprechpartner: Shelly Singh
Stadt:
Northbrook
Telefon: 18886006441
Kategorie:
Biotechnologie
Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 05.04.2019
Diese Pressemitteilung wurde bisher 593 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Mass Spectrometry Market | Sciex (US) Enhancing its Product Development Capabilities"
steht unter der journalistisch-redaktionellen Verantwortung von
MnM (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R
3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private
Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco
Weitere Mitteilungen von MnM
SEAT startet Projekt zur Umwandlung organischer Abfälle in Biokraftstoff ...
Wir alle wissen, dass Fahrzeuge mit Benzin, Strom und Gas betrieben werden können. Jetzt gibt es einen neuen Kraftstoff für Motoren, und der kommt aus unserem Abfalleimer. Dies ist das Ziel des Life Methamorphosis-Projekts: die Gewinnung von Biomethan aus organischen Abfällen durch Umwandlung
3D Cell Culture Market | Thermo Fisher (US) and Corning (US) Constantly Focuses on Strengthening its Product Portfolio ...
According to a new market research report "3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) - Global Forecast to 2022", pu
New Study Shows the Opportunities of Epigenetics in Personalized Medicine and Targeted Therapy ...
According to a new market research report "Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022&q
Jean-Baptiste Agnus verstärkt als Vice President of Sales and Marketing globales Führungsteam von Ajinomoto Bio-Pharma Services ...
Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), ein weltweit führender Anbieter von biopharmazeutischen Auftragsentwicklungs- und Fertigungsdienstleistungen, freut sich, bekannt geben zu können, dass Jean-Baptiste Agnus dem Unternehmen als Vice President of Sales and Marketing beig
